Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2008-10-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Relation Between Vitamin D Production and UVB Exposed Body Surface Area
NCT01042197
The Vitamin D Dose-Response Relationship
NCT01074541
Alternative Treatments of Vitamin D Deficiency
NCT01512537
Does Sunbed Radiation With Mainly UVA Provoke Cutaneous Vitamin D Synthesis in Humans?
NCT00516867
The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter
NCT02275650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Body surface area: 88 %
Broadband UVB
UVB dose: 1 SED every week
Group 2
Body surface area: 22 %
Broadband UVB
UVB dose: 4 SED every second week
Group 3
Body surface area: 88 %
Broadband UVB
UVB dose: 1 SED every second week
Group 4
Body surface area: 88 %
Broadband UVB
UVB dose: 1 SED every month
Group 5
Body surface area: 0 %
Control group
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Broadband UVB
UVB dose: 1 SED every week
Broadband UVB
UVB dose: 4 SED every second week
Broadband UVB
UVB dose: 1 SED every second week
Broadband UVB
UVB dose: 1 SED every month
Control group
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy
Exclusion Criteria
* Holiday or business travel south of 45 degrees latitude during trial
* Illness
* Drug addiction
* Pregnancy
* Lactating
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Danish Medical Research Council
OTHER
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bispebjerg Hospital, Department of Dermatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hans Christian Wulf, Professor
Role: STUDY_CHAIR
Bispebjerg Hospital, Department of Dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bispebjerg Hospital
Copenhagen, NV, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-C-2008-072
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.